# Reasoning-mode run — ED_Hospitalization — qid `ehr_bench_risk_prediction_858`

- **gold label:** `no`
- **final prediction:** `['yes']`

## Rendered user prompt (what the model saw)
```
<task_instruction>
Given the sequence of events that have occurred in a hospital, please predict whether the patient will be hospitalized after the emergency room visit.
All patient events needed for this task are already included below.
The current time is 2133-08-24 00:00:01, which is exactly one second after the latest observed event at 2133-08-24 00:00:00.
Use only the provided patient timeline.
Do not assume any unseen future events beyond the current time.
No EHR database lookup is needed for this record because the full timeline is embedded in the prompt.
Return only the final answer text as a single line. If candidate answers are provided, choose only from that candidate list.
</task_instruction>

<patient_info>
Current Time: 2133-08-24 00:00:01
</patient_info>

<patient_timeline>
## Patient Demographics [None]
- Anchor_Age: 63
- Gender: F

## Discharge [2132-08-16 00:00:00]
- Note_Type: DS
- Text:  
Name:  ___                      Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: ORTHOPAEDICS
 
Allergies: 
Percocet / Codeine / Grass ___, Standard / cats and 
dogs / Vicodin / maple trees / Hydromorphone
 
Attending: ___.
 
Chief Complaint:
right knee pain 
 
Major Surgical or Invasive Procedure:
___ Right total knee arthoplasty 

 
History of Present Illness:
___ year old female s/p L TKA in ___ presents electively 
for definitive treatment of her left knee pain
 
Past Medical History:
- IDDM since age ___ on insulin pump  
-h/o of "borderline" ovarian cancer-treated with TAH, no chemo  
at ___ (no longer in followup)  
- subaceous cyst of R breast-- ___ year hx, recently became 
infected in ___, pt had surgery for drainage and removal 
 
- rotator cuff injury in L shoulder-- awaiting surgery in late 
___.  
- urge incontinence  
- hypothyroidism  
- hypertension  
- glaucoma  
- foot surgery  
- sinus surgery ___ pt still has significant congestion 
and post-nasal drip  
- hx of intestinal obstruction  
.  

 
Social History:
___
Family History:
Breast ca: Brother at ___ y/o (BRCA negative), maternal aunt in 
___.  
Ovarian ca:PGM-treated with XRT in ___ and lived a long life  
Other: Father-lung and prostate  
Patient is ___.  

 
Physical Exam:
Well appearing in no acute distress  
 Afebrile with stable vital signs  
 Pain well-controlled  
 Respiratory: CTAB  
 Cardiovascular: RRR  
 Gastrointestinal: NT/ND  
 Genitourinary: Voiding independently  
 Neurologic: Intact with no focal deficits  
 Psychiatric: Pleasant, A&O x3  
 Musculoskeletal Lower Extremity:  
 * Incision healing well with staples  
 * Scant serosanguinous drainage  
 * Thigh full but soft  
 * No calf tenderness  
 * ___ strength  
 * SILT, NVI distally  
 * Toes warm  
 
Pertinent Results:
___ 12:50PM BLOOD WBC-6.6 RBC-2.52* Hgb-7.7* Hct-23.8* 
MCV-94 MCH-30.6 MCHC-32.4 RDW-13.6 RDWSD-47.0* Plt ___
___ 07:40AM BLOOD WBC-5.8 RBC-2.59* Hgb-7.9* Hct-24.2* 
MCV-93 MCH-30.5 MCHC-32.6 RDW-13.9 RDWSD-47.7* Plt ___
___ 05:42AM BLOOD WBC-7.6 RBC-2.66* Hgb-8.0* Hct-24.7* 
MCV-93 MCH-30.1 MCHC-32.4 RDW-13.6 RDWSD-46.3 Plt ___
___ 05:45AM BLOOD WBC-8.6 RBC-2.76* Hgb-8.5* Hct-25.6* 
MCV-93 MCH-30.8 MCHC-33.2 RDW-13.6 RDWSD-46.0 Plt ___
___ 05:45AM BLOOD WBC-7.9 RBC-2.87*# Hgb-8.7*# Hct-27.0*# 
MCV-94 MCH-30.3 MCHC-32.2 RDW-13.7 RDWSD-47.3* Plt ___
___ 10:10AM BLOOD ___
___ 12:50PM BLOOD Plt ___
___ 07:40AM BLOOD Plt ___
___ 07:40AM BLOOD ___
___ 05:42AM BLOOD Plt ___
___ 05:42AM BLOOD ___
___ 05:45AM BLOOD Plt ___
___ 05:45AM BLOOD ___
___ 05:45AM BLOOD Plt ___
___ 05:45AM BLOOD ___
___ 12:50PM BLOOD Glucose-168* UreaN-13 Creat-0.6 Na-135 
K-3.8 Cl-96 HCO3-34* AnGap-9
___ 07:40AM BLOOD Glucose-143* UreaN-12 Creat-0.5 Na-139 
K-3.5 Cl-100 HCO3-32 AnGap-11
___ 05:42AM BLOOD Glucose-205* UreaN-9 Creat-0.6 Na-134 
K-3.4 Cl-96 HCO3-32 AnGap-9
___ 05:45AM BLOOD Glucose-319* UreaN-10 Creat-0.8 Na-130* 
K-3.4 Cl-92* HCO3-32 AnGap-9
___ 05:45AM BLOOD Glucose-147* UreaN-17 Creat-0.8 Na-134 
K-3.6 Cl-99 HCO3-30 AnGap-9
___ 12:50PM BLOOD Calcium-8.7 Phos-2.2* Mg-2.0
___ 07:40AM BLOOD Calcium-8.8 Phos-3.5 Mg-2.2
___ 05:42AM BLOOD Calcium-8.8 Phos-2.5* Mg-2.0
___ 05:45AM BLOOD Calcium-9.0 Phos-2.3* Mg-2.0
___ 05:45AM BLOOD Calcium-8.3* Phos-2.9 Mg-1.9
 
Brief Hospital Course:
The patient was admitted to the orthopedic surgery service and 
was taken to the operating room for above described procedure. 
Please see separately dictated operative report for details. The 
surgery was uncomplicated and the patient tolerated the 
procedure well. Patient received perioperative IV antibiotics.

Postoperative course was remarkable for the following:
On POD#1, the patient was given a bolus of 500mL of fluid with 
oliguria and orthostasis with physical therapy.  She was given 
7mg of Coumadin for an INR of 1.2.

On POD#2, ___ was given 500cc of fluid for hypontremia. She 
was given 8mg of Coumadin for an INR of 1.6.  Her insulin pump 
was malfunctioning.  A sliding scale was written for if blood 
glucose levels were elevated.

On POD#3, her sodium stabilized.  Her fluid restriction was 
discontinued.  She was given 2.5 mg for an INR level of 2.  Her 
Lovenox was discontinued.

On POD#4, her INR level of 2 and Coumadin was dosed at 5 mg.  
Her blood sugars were as low as 31 and also into the 300s.  The 
patient was given an additional Humalog (when her blood sugars 
were elevated) as well as making adjustments in her basal and 
pre-prandial dosing.

On POD#5, her INR level was 1.9 and Coumadin was dosed at 5 mg.  
Her blood sugars had stabilized at time of discharge.

Otherwise, pain was controlled with a combination of IV and oral 
pain medications.  The patient received Lovenox to Coumadin 
bridge for DVT prophylaxis starting on the morning of POD#1.  
She was discharged on 6 weeks of Coumadin.  The Lovenox was 
discontinued once the INR was greater than 2 (POD#3).  The foley 
was removed and the patient was voiding independently 
thereafter. The surgical dressing was changed on POD#2 and the 
surgical incision was found to be clean and intact without 
erythema or abnormal drainage. The patient was seen daily by 
physical therapy. Labs were checked throughout the hospital 
course and repleted accordingly. At the time of discharge the 
patient was tolerating a regular diet and feeling well.  The 
patient was afebrile with stable vital signs.  The patient's 
hematocrit was acceptable and pain was adequately controlled on 
an oral regimen. The operative extremity was neurovascularly 
intact and the wound was benign. 

The patient's weight-bearing status is weight bearing as 
tolerated on the operative extremity.

___ is discharged to home with services in stable 
condition.

 
Medications on Admission:
1. Acetaminophen 1000 mg PO Q8H:PRN pain 
2. Aspirin 81 mg PO DAILY 
3. Astepro (azelastine) 0.15 % (205.5 mcg) nasal bid 
4. Combigan (brimonidine-timolol) 0.2-0.5 % ophthalmic TID 
5. Fluticasone Propionate NASAL 2 SPRY NU DAILY 
6. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS 
7. Levothyroxine Sodium 88 mcg PO 6X/WEEK (___) 
8. Levothyroxine Sodium 176 mcg PO 1X/WEEK (___) 
9. Multivitamins 1 TAB PO DAILY 
10. Vitamin D 400 UNIT PO DAILY 
11. Albuterol Inhaler ___ PUFF IH Q6H:PRN cough 
12. Flovent HFA (fluticasone) 220 mcg/actuation inhalation 2 
puffs bid prn cough 
13. Ibuprofen 600 mg PO DAILY:PRN pain 
14. psyllium husk 3.4 grams oral daily 
15. Insulin  Pump SC (Self Administering Medication)Insulin 
Aspart (Novolog) (non-formulary)
Basal rate minimum: 0.4 units/hr
Basal rate maximum: 0.7 units/hr
Target glucose: ___
Fingersticks: QAC and HS
16. CloniDINE 0.1 mg PO DAILY 
17. Enalapril Maleate 20 mg PO DAILY 
18. Glucagon 1 mg SUBCUT AS DIRECTED FOR LOW BLOOD SUGAR 
19. Hydrochlorothiazide 12.5 mg PO DAILY 
20. NovoLOG (insulin aspart) 100 unit/mL subcutaneous up to 40 
units via pump daily 
21. Lantus (insulin glargine) 100 unit/mL subcutaneous 12 units 
subcutaneously at bedtime when pump not in use 
22. NIFEdipine CR 30 mg PO DAILY 
23. Citracal + D Petites (calcium citrate-vitamin D3) 200 mg 
calcium -250 unit oral BID 
24. Polyethylene Glycol 17 g PO DAILY:PRN constipation 
25. Ocuvite (vit C-vit E-lutein-min-om-3) 150-30-5-150 
mg-unit-mg-mg oral DAILY 

 
Discharge Medications:
1. Albuterol Inhaler ___ PUFF IH Q6H:PRN cough 
2. CloniDINE 0.1 mg PO DAILY 
3. Enalapril Maleate 20 mg PO DAILY 
4. Flovent HFA (fluticasone) 220 mcg/actuation inhalation 2 
puffs bid prn cough 
5. Fluticasone Propionate NASAL 2 SPRY NU DAILY 
6. Glucagon 1 mg SUBCUT AS DIRECTED FOR LOW BLOOD SUGAR 
7. Hydrochlorothiazide 12.5 mg PO DAILY 
8. Insulin  Pump SC (Self Administering Medication)Insulin 
Aspart (Novolog) (non-formulary)
Basal rate minimum: 0.4 units/hr
Basal rate maximum: 0.7 units/hr
Target glucose: ___
Fingersticks: QAC and HS
9. Levothyroxine Sodium 88 mcg PO 6X/WEEK (___) 
10. Levothyroxine Sodium 176 mcg PO 1X/WEEK (___) 
11. Multivitamins 1 TAB PO DAILY 
12. NIFEdipine CR 30 mg PO DAILY 
13. Polyethylene Glycol 17 g PO DAILY:PRN constipation 
14. Vitamin D 400 UNIT PO DAILY 
15. Bisacodyl 10 mg PO/PR DAILY:PRN Constipation 
16. Docusate Sodium 100 mg PO BID 
17. Gabapentin 300 mg PO TID 
18. Senna 8.6 mg PO BID 
19. Aspirin 81 mg PO DAILY 
20. Astepro (azelastine) 0.15 % (205.5 mcg) nasal bid 
21. Citracal + D Petites (calcium citrate-vitamin D3) 200 mg 
calcium -250 unit oral BID 
22. Combigan (brimonidine-timolol) 0.2-0.5 % ophthalmic TID 
23. Lantus (insulin glargine) 100 unit/mL SUBCUTANEOUS 12 UNITS 
SUBCUTANEOUSLY AT BEDTIME WHEN PUMP NOT IN USE 
24. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS 
25. NovoLOG (insulin aspart) 100 unit/mL SUBCUTANEOUS UP TO 40 
UNITS VIA PUMP DAILY 
26. Ocuvite (vit C-vit E-lutein-min-om-3) 150-30-5-150 
mg-unit-mg-mg oral DAILY 
27. psyllium husk 3.4 grams oral daily 
28. Acetaminophen 1000 mg PO Q8H:PRN pain 
29. Brimonidine Tartrate 0.15% Ophth. 1 DROP BOTH EYES Q8H 
30. Warfarin 2.5 mg PO ___ 
You will be on it for 6 weeks and it will be managed by the 
___ clinic.  
31. Morphine Sulfate ___ ___ mg PO Q4H:PRN pain 

 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
right knee osteoarthritis 

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - requires assistance or aid (walker 
or cane).

 
Discharge Instructions:
1. Please return to the emergency department or notify your 
physician if you experience any of the following: severe pain 
not relieved by medication, increased swelling, decreased 
sensation, difficulty with movement, fevers greater than 101.5, 
shaking chills, increasing redness or drainage from the incision 
site, chest pain, shortness of breath or any other concerns.

2. Please follow up with your primary physician regarding this 
admission and any new medications and refills. 

3. Resume your home medications unless otherwise instructed.

4. You have been given medications for pain control. Please do 
not drive, operate heavy machinery, or drink alcohol while 
taking these medications. As your pain decreases, take fewer 
tablets and increase the time between doses. This medication can 
cause constipation, so you should drink plenty of water daily 
and take a stool softener (such as Colace) as needed to prevent 
this side effect.  Call your surgeons office 3 days before you 
are out of medication so that it can be refilled.  These 
medications cannot be called into your pharmacy and must be 
picked up in the clinic or mailed to your house.  Please allow 
an extra 2 days if you would like your medication mailed to your 
home.

5. You may not drive a car until cleared to do so by your 
surgeon.

6. Please call your surgeon's office to schedule or confirm your 
follow-up appointment.

7. SWELLING: Ice the operative joint 20 minutes at a time, 
especially after activity or physical therapy. Do not place ice 
directly on the skin. You may wrap the knee with an ace bandage 
for added compression. Please DO NOT take any non-steroidal 
anti-inflammatory medications (NSAIDs such as Celebrex, 
ibuprofen, Advil, Aleve, Motrin, naproxen etc).

8. ANTICOAGULATION: Please continue your Coumadin for six 
(6)weeks to help prevent deep vein thrombosis (blood clots).  
Your INR will be managed by the ___ clinic.  If you 
were taking aspirin prior to your surgery, it is OK to continue 
at your previous dose while taking this medication. 

9. WOUND CARE: Please keep your incision clean and dry. It is 
okay to shower five days after surgery but no tub baths, 
swimming, or submerging your incision until after your four (4) 
week checkup. Please place a dry sterile dressing on the wound 
each day if there is drainage, otherwise leave it open to air. 
Check wound regularly for signs of infection such as redness or 
thick yellow drainage. Staples will be removed at your follow-up 
appointment in two weeks.

10. ___ (once at home): Home ___, dressing changes as 
instructed, wound checks.

11. ACTIVITY: Weight bearing as tolerated on the operative 
extremity. Mobilize.  ROM as tolerated. No strenuous exercise or 
heavy lifting until follow up appointment.

 

Physical Therapy:
WBAT RLE
ROMAT
Mobilize frequently
Treatments Frequency:
daily dressing changes as needed for drainage
wound checks daily
ice
staple removal and replace with steri-strips (at your first 
follow up visit POD14-17)
 
Followup Instructions:
___




## EDstays [2132-08-23 21:38:00]
- Gender: F
- Race: WHITE

## Triage [2132-08-23 21:38:01]
- Temperature: 97.8
- Heartrate: 112.0
- Resprate: 18.0
- O2Sat: 96.0
- Sbp: 153.0
- Dbp: 68.0
- Pain: 1
- Acuity: 2.0
- Chiefcomplaint: Vomiting

## Vitalsign [2132-08-23 21:39:00]
- Temperature: 97.8
- Heartrate: 112.0
- Resprate: 18.0
- O2Sat: 96.0
- Sbp: 153.0
- Dbp: 68.0
- Pain: 1
- Rhythm: nan

## Electronic Medicine Administration Record [2132-08-23 22:15:00]
- Medication: nan
- Event_Txt: Administered

## Medrecon [2132-08-23 22:17:00]
| Name | Atc Type |
| ------ | ------ |
| acetaminophen | None |
| albuterol sulfate | nan |
| aspirin | acetylsalicylic acid |
| aspirin | acetylsalicylic acid |
| azelastine [Astepro] | nan |
| bisacodyl | bisacodyl |
| brimonidine-timolol [Combigan] | timolol, combinations |
| calcium citrate-vitamin D3 [Citracal + D Petites] | calcium compounds |
| cholecalciferol (vitamin D3) | colecalciferol, combinations |
| clonidine HCl | None |
| docusate sodium | docusate sodium |
| enalapril maleate | enalapril |
| fluticasone | fluticasone |
| fluticasone [Flovent HFA] | nan |
| gabapentin | gabapentin |
| glucagon (human recombinant) [Glucagon Emergency] | glucagon |
| hydrochlorothiazide | nan |
| ibuprofen | ibuprofen |
| insulin aspart [Novolog] | None |
| insulin glargine [Lantus] | nan |
| latanoprost | nan |
| levothyroxine [Synthroid] | levothyroxine sodium |
| morphine | morphine |
| Multivitamin | None |
| nifedipine | nan |
| ondansetron | nan |
| One Touch Ultra Test | nan |
| One Touch Ultra Test | nan |
| polyethylene glycol 3350 | macrogol |
| psyllium husk (with sugar) [Metamucil] | nan |
| sennosides | senna glycosides |
| vit C-vit E-lutein-min-om-3 [Ocuvite] | None |
| vit C-vit E-lutein-min-om-3 [Ocuvite] | None |
| warfarin | warfarin |

## Labotary Test Events [2132-08-23 22:20:00]
| Item_Name | Valuenum | Valueuom | Ref_Range_Lower | Ref_Range_Upper | Flag | Comments |
| ------ | ------ | ------ | ------ | ------ | ------ | ------ |
| Absolute Lymphocyte Count | 0.8 | K/uL | 1.2 | 3.7 | abnormal | nan |
| Anisocytosis | nan | nan | nan | nan | nan | OCCASIONAL. |
| Atypical Lymphocytes | 0.0 | % | 0.0 | 0.0 | nan | nan |
| Bands | 5.0 | % | 0.0 | 5.0 | nan | nan |
| Basophils | 0.0 | % | 0.0 | 1.0 | nan | nan |
| Eosinophils | 1.0 | % | 1.0 | 7.0 | nan | nan |
| Hematocrit | 26.2 | % | 34.0 | 45.0 | abnormal | nan |
| Hemoglobin | 8.4 | g/dL | 11.2 | 15.7 | abnormal | nan |
| Hypochromia | nan | nan | nan | nan | nan | OCCASIONAL. |
| Lymphocytes | 5.0 | % | 19.0 | 53.0 | abnormal | nan |
| Macrocytes | nan | nan | nan | nan | nan | 1+. |
| MCH | 30.1 | pg | 26.0 | 32.0 | nan | nan |
| MCHC | 32.1 | g/dL | 32.0 | 37.0 | nan | nan |
| MCV | 94.0 | fL | 82.0 | 98.0 | nan | nan |
| Metamyelocytes | 1.0 | % | 0.0 | 0.0 | abnormal | nan |
| Microcytes | nan | nan | nan | nan | nan | OCCASIONAL. |
| Monocytes | 2.0 | % | 5.0 | 13.0 | abnormal | nan |
| Myelocytes | 0.0 | % | 0.0 | 0.0 | nan | nan |
| Neutrophils | 86.0 | % | 34.0 | 71.0 | abnormal | nan |
| Platelet Count | 606.0 | K/uL | 150.0 | 400.0 | abnormal | nan |
| Platelet Smear | nan | nan | nan | nan | nan | VERY HIGH. |
| Poikilocytosis | nan | nan | nan | nan | nan | NORMAL. |
| Polychromasia | nan | nan | nan | nan | nan | NORMAL. |
| RDW | 14.7 | % | 10.5 | 15.5 | nan | nan |
| Red Blood Cells | 2.79 | m/uL | 3.9 | 5.2 | abnormal | nan |
| White Blood Cells | 16.0 | K/uL | 4.0 | 10.0 | abnormal | nan |
| Absolute Basophil Count | 0.0 | K/uL | 0.01 | 0.08 | abnormal | nan |
| Absolute Eosinophil Count | 0.16 | K/uL | 0.04 | 0.54 | nan | nan |
| Absolute Monocyte Count | 0.32 | K/uL | 0.2 | 0.8 | nan | nan |
| Absolute Neutrophil Count | 14.56 | K/uL | 1.6 | 6.1 | abnormal | nan |
| RDW-SD | 48.7 | fL | 35.1 | 46.3 | abnormal | nan |
| Anion Gap | 18.0 | mEq/L | 8.0 | 20.0 | nan | nan |
| Bicarbonate | 28.0 | mEq/L | 22.0 | 32.0 | nan | nan |
| Calcium, Total | 9.6 | mg/dL | 8.4 | 10.3 | nan | nan |
| Chloride | 86.0 | mEq/L | 96.0 | 108.0 | abnormal | nan |
| Creatinine | 0.8 | mg/dL | 0.4 | 1.1 | nan | nan |
| Glucose | 275.0 | mg/dL | 70.0 | 100.0 | abnormal | IF FASTING, 70-100 NORMAL, >125 PROVISIONAL DIABETES. |
| Magnesium | 1.8 | mg/dL | 1.6 | 2.6 | nan | nan |
| Phosphate | 3.1 | mg/dL | 2.7 | 4.5 | nan | nan |
| Potassium | 4.4 | mEq/L | 3.3 | 5.1 | nan | nan |
| Sodium | 128.0 | mEq/L | 133.0 | 145.0 | abnormal | nan |
| Urea Nitrogen | 27.0 | mg/dL | 6.0 | 20.0 | abnormal | nan |
| Blue Top Hold | nan | nan | nan | nan | nan | ___ |
| Base Excess | 7.0 | mEq/L | nan | nan | nan | nan |
| Calculated Total CO2 | 34.0 | mEq/L | 21.0 | 30.0 | abnormal | nan |
| Lactate | 1.1 | mmol/L | 0.5 | 2.0 | nan | nan |
| pCO2 | 48.0 | mm Hg | 35.0 | 45.0 | abnormal | nan |
| pH | 7.45 | units | 7.35 | 7.45 | nan | nan |
| pO2 | 76.0 | mm Hg | 85.0 | 105.0 | abnormal | nan |
| Specimen Type | nan | nan | nan | nan | nan | ___ |

## Electronic Medicine Administration Record [2132-08-24 00:18:00]
- Medication: nan
- Event_Txt: Administered

## Vitalsign [2132-08-24 00:49:00]
- Temperature: 97.7
- Heartrate: 98.0
- Resprate: 16.0
- O2Sat: 99.0
- Sbp: 125.0
- Dbp: 78.0
- Pain: 0
- Rhythm: nan

## ED Diagnoses on International Classification of Diseases [2132-08-24 00:54:00]
| Icd_Title | Ccs Type |
| ------ | ------ |
| Nausea with vomiting, unspecified | Nausea and vomiting |
| Adverse effect of other opioids, initial encounter | E Codes: Adverse effects of medical drugs |
| Oth places as the place of occurrence of the external cause | E Codes: Place of occurrence |
| Type 2 diabetes mellitus without complications | Diabetes mellitus without complication |
| Long term (current) use of insulin | Other aftercare |
| Essential (primary) hypertension | Essential hypertension |

## Labotary Test Events [2132-08-25 19:55:00]
| Item_Name | Valuenum | Valueuom | Ref_Range_Lower | Ref_Range_Upper | Flag | Comments |
| ------ | ------ | ------ | ------ | ------ | ------ | ------ |
| Bacteria | nan | nan | nan | nan | nan | NONE. |
| Bilirubin | nan | mg/dL | nan | nan | nan | NEG. |
| Blood | nan | nan | nan | nan | nan | NEG. |
| Epithelial Cells | nan | #/hpf | nan | nan | nan | <1. |
| Glucose | 70.0 | mg/dL | nan | nan | nan | nan |
| Ketone | nan | mg/dL | nan | nan | nan | NEG. |
| Leukocytes | nan | nan | nan | nan | nan | NEG. |
| Nitrite | nan | nan | nan | nan | nan | NEG. |
| pH | 8.0 | units | 5.0 | 8.0 | nan | nan |
| Protein | nan | mg/dL | nan | nan | nan | TR. |
| RBC | 1.0 | #/hpf | 0.0 | 2.0 | nan | nan |
| Specific Gravity | 1.017 |   | 1.001 | 1.035 | nan | nan |
| Urine Appearance | nan | nan | nan | nan | nan | Clear. |
| Urine Color | nan | nan | nan | nan | nan | Yellow. |
| Urobilinogen | nan | mg/dL | 0.2 | 1.0 | nan | NEG. |
| WBC | 3.0 | #/hpf | 0.0 | 5.0 | nan | nan |
| Yeast | nan | nan | nan | nan | nan | nan |

## Online Medical Record [2133-03-10 00:00:00]
- Result_Name: Blood Pressure
- Result_Value: 104/68

## Radiology Examinations [2133-04-16 12:59:00]
| Note_Type | Exam_Name | Text |
| ------ | ------ | ------ |
| AR | None | ADDENDUM  RECOMMENDATION(S):
Age and risk appropriate screening recommended.
 |
| RR | ['H DIGITAL SCREENING W/TOMO & CAD'] | EXAMINATION:  BILATERAL DIGITAL SCREENING MAMMOGRAM INTERPRETED WITH CAD AND
3D DIGITAL BREAST TOMOSYNTHESIS

INDICATION:  Screening.  Patient is nulliparous.  Personal history of right
breast cyst infection and removal without visible scar as well as
premenopausal ovarian cancer.  Family history of breast cancer in brother at
age ___ and maternal aunt, age unspecified.

COMPARISON:  Mammograms from ___,
___

TECHNIQUE:  Digital 2D CC and MLO views and 3D tomosynthesis CC and MLO views
were obtained.  Computer aided detection was utilized and assisted with
interpretation.

FINDINGS: 

Tissue density: B - There are scattered areas of fibroglandular density. 
Benign calcifications in the left upper outer breast are stable.
There is no dominant mass, unexplained architectural distortion or suspicious
grouped microcalcifications in either breast.  There is no significant change.

IMPRESSION: 

No specific evidence of malignancy.

RECOMMENDATION(S):  Annual mammography.

NOTIFICATION:  A summary letter will be sent to the patient with this result.

BI-RADS: 2 Benign.


 |

## Online Medical Record [2133-04-20 00:00:00]
| Result_Name | Result_Value |
| ------ | ------ |
| Blood Pressure | 109/73 |
| BMI (kg/m2) | 24.6 |
| Weight (Lbs) | 148 |

## Labotary Test Events [2133-05-17 11:25:00]
| Item_Name | Valuenum | Valueuom | Ref_Range_Lower | Ref_Range_Upper | Flag | Comments |
| ------ | ------ | ------ | ------ | ------ | ------ | ------ |
| Absolute Lymphocyte Count | 1.37 | K/uL | 1.2 | 3.7 | nan | nan |
| Basophils | 1.0 | % | 0.0 | 1.0 | nan | nan |
| Eosinophils | 3.9 | % | 1.0 | 7.0 | nan | nan |
| Hematocrit | 38.5 | % | 34.0 | 45.0 | nan | nan |
| Hemoglobin | 12.4 | g/dL | 11.2 | 15.7 | nan | nan |
| Lymphocytes | 28.3 | % | 19.0 | 53.0 | nan | nan |
| MCH | 30.3 | pg | 26.0 | 32.0 | nan | nan |
| MCHC | 32.2 | g/dL | 32.0 | 37.0 | nan | nan |
| MCV | 94.0 | fL | 82.0 | 98.0 | nan | nan |
| Monocytes | 7.9 | % | 5.0 | 13.0 | nan | nan |
| Neutrophils | 58.3 | % | 34.0 | 71.0 | nan | nan |
| Platelet Count | 342.0 | K/uL | 150.0 | 400.0 | nan | nan |
| RDW | 13.8 | % | 10.5 | 15.5 | nan | nan |
| Red Blood Cells | 4.09 | m/uL | 3.9 | 5.2 | nan | nan |
| White Blood Cells | 4.8 | K/uL | 4.0 | 10.0 | nan | nan |
| Absolute Basophil Count | 0.05 | K/uL | 0.01 | 0.08 | nan | nan |
| Absolute Eosinophil Count | 0.19 | K/uL | 0.04 | 0.54 | nan | nan |
| Absolute Monocyte Count | 0.38 | K/uL | 0.2 | 0.8 | nan | nan |
| Absolute Neutrophil Count | 2.82 | K/uL | 1.6 | 6.1 | nan | nan |
| Immature Granulocytes | 0.6 | % | nan | nan | nan | ___ |
| RDW-SD | 47.8 | fL | 35.1 | 46.3 | abnormal | nan |
| Ferritin | 52.0 | ng/mL | 13.0 | 150.0 | nan | nan |
| H | 3.0 | nan | nan | nan | nan | nan |
| I | 1.0 | nan | nan | nan | nan | nan |
| Iron | 89.0 | ug/dL | 30.0 | 160.0 | nan | nan |
| Iron Binding Capacity, Total | 274.0 | ug/dL | 260.0 | 470.0 | nan | nan |
| Transferrin | 211.0 | mg/dL | 200.0 | 360.0 | nan | nan |
| Vitamin B12 | 774.0 | pg/mL | 240.0 | 900.0 | nan | nan |
| L | 5.0 | nan | nan | nan | nan | nan |

## Radiology Examinations [2133-05-28 09:05:00]
| Note_Type | Exam_Name | Text |
| ------ | ------ | ------ |
| RR | ['MR DEFECOGRAM'] | EXAMINATION:  MR ___

INDICATION:  ___ year old woman with idiopathic constipation with concern for
prolapse and pelvic floor dysfunction  // pelvic floor dysfunction and
possible prolapse

TECHNIQUE:  240 cc of ultrasound gel was instilled in the rectum prior to the
examination. T2 weighted multiplanar images of the pelvis were acquired within
a 1.5 Tesla magnet, including sagittal dynamic sequences performed at rest and
during squeezing and defecation.

COMPARISON:  None.

FINDINGS: 

MRI OF THE PELVIS WITHOUT IV CONTRAST:
The patient is status post hysterectomy.

RESTING:
The anorectal junction is 2.5 cm below the pubococcygeal line.
The bladder is 1.9 cm above the pubococcygeal line.
The vaginal cuff is 6.3 cm above the pubococcygeal line.
An enterocele is not present.
A sigmoidocele is not present.

SQUEEZING:
There is contraction of the puborectalis muscle with the angle along the
puborectalis becoming more acute, decreasing from 115 degrees to 80 degrees.
The anorectal junction is 2.2 cm below the pubococcygeal line.
The bladder is 2.2 cm above the pubococcygeal line.
The vaginal cuff is 6.0 cm above the pubococcygeal line.

DEFECATION:
There is incomplete emptying of the rectal vault.
The anal sphincter relaxes normally.
Rectal prolapse is not present.
The anorectal junction is 5.2 cm below the pubococcygeal line.
The bladder is 0.4 cm below the pubococcygeal line.
The vaginal cuff is 3.4 cm above the pubococcygeal line.

An enterocele is not present.
A sigmoidocele is not present.
An anterior rectocele is present, measuring 2.9 cm.

IMPRESSION:



1. Markedly abnormal descent the posterior compartment with a moderate
anterior rectocele.
2. Essentially normal fraction of the anterior and middle compartments.
 |
| RR | ['KNEE (3 VIEWS) BILAT'] | EXAMINATION:  KNEE (3 VIEWS) BILATERAL

INDICATION:  ___ year old woman with bilateral knee pain  // bilateral knee
pain      bilateral knee pain

IMPRESSION: 

There are total knee arthroplasties bilaterally that appear well seated
without hardware-related complication.  All there is a bony opacification
inferior to the patella.  Is unclear whether this represents a sequela of an
interval fracture or possible free joint body.  Similarly, there are 2
opacifications posteriorly that were not seen on the previous examination.
 |

## Online Medical Record [2133-08-24 00:00:00]
| Result_Name | Result_Value |
| ------ | ------ |
| Blood Pressure | 148/76 |
| BMI (kg/m2) | 24.6 |
| Height (Inches) | 65 |
| Weight (Lbs) | 147.8 |

## Prescriptions [None]
- Drug: Insulin Pump (Self Administering Medication)
- Atc Type: None
- Prod_Strength: nan
- Dose_Val_Rx: nan
- Dose_Unit_Rx: nan

## Diagnoses on International Classification of Diseases [None]
| Diagnoses | Ccs Type |
| ------ | ------ |
| Osteoarthrosis, localized, primary, lower leg | Osteoarthritis |
| Unspecified acquired hypothyroidism | Thyroid disorders |
| Insulin pump status | Diabetes mellitus without complication |
| Long-term (current) use of insulin | Other aftercare |
| Unspecified essential hypertension | Essential hypertension |
| Unspecified glaucoma | Glaucoma |
| Urge incontinence | Genitourinary symptoms and ill-defined conditions |
| Personal history of malignant neoplasm of ovary | Cancer of ovary |
| Long-term (current) use of anticoagulants | Other aftercare |
| Diabetes mellitus without mention of complication, type I [juvenile type], not stated as uncontrolled | Diabetes mellitus without complication |
| Asthma, unspecified type, unspecified | Asthma |
| Hyperparathyroidism, unspecified | Other endocrine disorders |



## Prescriptions [None]
- Drug: Insulin Pump (Self Administering Medication)
- Atc Type: None
- Prod_Strength: nan
- Dose_Val_Rx: nan
- Dose_Unit_Rx: nan

## Diagnoses on International Classification of Diseases [None]
| Diagnoses | Ccs Type |
| ------ | ------ |
| Osteoarthritis of knee, unspecified | Osteoarthritis |
| Type 1 diabetes mellitus with diabetic polyneuropathy | Diabetes mellitus with complications |
| Hypo-osmolality and hyponatremia | Fluid and electrolyte disorders |
| Presence of left artificial knee joint | Other connective tissue disease |
| Personal history of malignant neoplasm of ovary | Cancer of ovary |
| Hypothyroidism, unspecified | Thyroid disorders |
| Essential (primary) hypertension | Essential hypertension |
| Unspecified asthma, uncomplicated | Asthma |
| Postprocedural (acute) (chronic) kidney failure | Complications of surgical procedures or medical care |
| Unspecified glaucoma | Glaucoma |
| Family history of malignant neoplasm of breast | Residual codes; unclassified |
| Family history of malignant neoplasm of ovary | Residual codes; unclassified |
| Family history of malignant neoplasm of trachea, bronchus and lung | Residual codes; unclassified |
| Family history of malignant neoplasm of prostate | Residual codes; unclassified |
| Long term (current) use of insulin | Other aftercare |



## Microbiology Test Events [None]
| Test_Name | Dilution_Text | Interpretation | Comments | Ab_Name |
| ------ | ------ | ------ | ------ | ------ |
| URINE CULTURE | nan | nan | MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT WITH SKIN AND/OR GENITAL CONTAMINATION.   | nan |
| URINE CULTURE | nan | nan | NO GROWTH.   | nan |



## Diagnoses on International Classification of Diseases [None]
| Diagnoses | Ccs Type |
| ------ | ------ |
| Cellulitis and abscess of finger, unspecified | Skin and subcutaneous tissue infections |
| Diabetes mellitus without mention of complication, type I [juvenile type], not stated as uncontrolled | Diabetes mellitus without complication |
| Unspecified essential hypertension | Essential hypertension |
| Unspecified acquired hypothyroidism | Thyroid disorders |
| Arthropathy, unspecified, site unspecified | Other non-traumatic joint disorders |
| Long-term (current) use of aspirin | Other aftercare |



## Diagnoses on International Classification of Diseases [None]
| Diagnoses | Ccs Type |
| ------ | ------ |
| Diabetes with other specified manifestations, type I [juvenile type], not stated as uncontrolled | Diabet
…[truncated]
```

## Assistant reply (full)
```
Looking at the patient timeline, I need to determine if the patient will be hospitalized after the emergency room visit.

The ED stay occurred on 2132-08-23, with chief complaint of vomiting. The ED diagnoses include nausea with vomiting, adverse effect of opioids, diabetes, and hypertension. 

Key observations:
1. The patient had recently undergone right total knee arthroplasty and was discharged home on 2132-08-16 with morphine for pain.
2. She presented to the ED on 2132-08-23 with vomiting (likely opioid-related adverse effect).
3. Labs showed hyponatremia (Na 128), elevated WBC (16.0), anemia (Hgb 8.4), and elevated glucose (275).
4. There are lab results from 2132-08-25 (urinalysis), which is AFTER the ED visit, suggesting the patient was still in the hospital getting labs done - this indicates she was admitted.
5. The diagnoses list includes entries mentioning "Nausea with vomiting," "Acidosis," "Anemia," "Tachycardia," along with "Hypo-osmolality and hyponatremia" in another diagnosis set, which are consistent with an inpatient admission.
6. The significant lab abnormalities (hyponatremia, leukocytosis, anemia, metabolic issues) in a complex diabetic patient on an insulin pump would likely warrant admission.

The presence of lab results on 2132-08-25 (two days after the ED visit) strongly suggests the patient was admitted.

<answer>yes</answer>
```